Discover 644 paid clinical trials in Charlotte, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Charlotte offers many opportunities to participate in clinical research focused on various conditions, including cancer, lymphoma, heart disease, and cystic fibrosis. The city’s medical research institutions are recruiting both healthy volunteers interested in paid trials, as well as individuals with specific health conditions.
Filter
2
Filter results
Results: 644
FeaturedActive & Responsive
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
for
Rheumatoid Arthritis
Location: Charlotte NC, Summerville SC, Jacksonville FL,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06972446
Phase2, Recruiting
FeaturedActive & Responsive
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
for
Moderately to Severely Active Ulcerative Colitis
Location: Charlotte NC, High Point NC, Greenville SC, Roanoke VA,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 16 - 70+
Code: NCT06588855
Phase3, Recruiting
FeaturedActive & Responsive
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
for
Moderately to Severely Active Crohns Disease
Location: Charlotte NC, Monroe NC, Greenville SC, Roanoke VA,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 16 - 70+
Code: NCT06819878
Phase3, Recruiting
Featured
Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma
for
Multiple Myeloma
Location: Charlotte NC, Winston-Salem NC, Atlanta GA,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT07555938
Phase3, Recruiting
Featured
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
for
Breast Cancer
Location: Charlotte NC, Winston-Salem NC, Atlanta GA, Norfolk VA,
Sponsor: Genentech, Inc.
Sex: All
Age: 18+
Code: NCT07100106
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Featured
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
for
Breast Cancer
Location: Charlotte NC, Winston-Salem NC, Greenville SC,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT06790693
Phase3, Recruiting
Featured
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
for
Moderately to Severely Active Crohns Disease
Location: Charlotte NC, High Point NC, Atlanta GA, Richmond VA,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 16 - 70+
Code: NCT06819891
Phase3, Recruiting
Featured
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer
for
Inoperable, Locally Advanced or Metastatic, ER-positive Breast Cancer,
Location: Charlotte NC, Philadelphia PA, Germantown TN, Boston MA,
Sponsor: Hoffmann-La Roche
Sex: Female
Age: 18+
Code: NCT04802759
Phase1, Phase2, Recruiting
Featured
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
for
Epithelial Ovarian Cancer, Fallopian Tube Cancer,
Location: Charlotte NC, Winston-Salem NC, Chapel Hill NC,
Sponsor: AbbVie
Sex: Female
Age: 18+
Code: NCT06890338
Phase2, Recruiting
Featured
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
for
Multiple Myeloma
Location: Charlotte NC, Winston-Salem NC, Chapel Hill NC,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06953960
Phase1, Phase2, Recruiting
Featured
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
for
Metastatic Breast Cancer
Location: Charlotte NC, Washington D.C. DC, Hyattsville MD,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT05894239
Phase3, Recruiting
Featured
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
for
Migraine
Location: Charlotte NC, Greenville SC, Atlanta GA, Savannah GA,
Sponsor: AbbVie
Sex: All
Age: 6 - 17
Code: NCT05125302
Phase3, Recruiting
Featured
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Location: Charlotte NC, Winston-Salem NC, Columbia SC,
Sponsor: 89bio, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06419374
Phase3, Recruiting
Featured
A Study to Assess the Adverse Events, Change in Disease Activity, and How Oral ABBV-711 Tablets Move Through the Body as a Monotherapy and in Combination With Intravenously Infused Budigalimab (ABBV-181), in Adults With Advanced Squamous Tumors
for
Advanced Squamous Tumors
Location: Huntersville NC, Chicago IL, Toronto, Grand Rapids MI,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07241039
Phase1, Recruiting
FeaturedNew
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
for
Obesity, Overweight
Location: Monroe NC, Greensboro NC, Danville VA, Bristol TN,
Sponsor: AbbVie
Sex: All
Age: 18 - 70+
Code: NCT07752979
Phase2, Recruiting
Featured
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
for
Ulcerative Colitis
Location: Monroe NC, Kissimmee FL, Fresh Meadows NY, Chicago IL,
Sponsor: Genentech, Inc.
Sex: All
Age: 18+
Code: NCT06979336
Phase2, Recruiting
Featured
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
for
Neovascular Age-related Macular Degeneration
Location: Hickory NC, Austin TX
Sponsor: Genentech, Inc.
Sex: All
Age: 50+
Code: NCT04853251
Recruiting
Active & ResponsiveNew
Leveraging Chatbot to Improve PrEP in the Southern United States
for
HIV Prevention, PrEP Awareness, PrEP Uptake
Location: Charlotte NC, Atlanta GA, Pembroke Pines FL, Miami FL
Sponsor: Yale University
Sex: Male
Age: 18+
Code: NCT05968755
Recruiting
Active & Responsive
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
for
Generalized Myasthenia Gravis
Location: Charlotte NC, Chapel Hill NC, Durham NC, Augusta GA,